Digitalis Investigation Group (DIG)

• Status: Completed
• Trial end date: 1998-06-01
• Target enrollment: 0
• Participant gender: All

Summary

To determine if digitalis had a beneficial, harmful, or no effect on total mortality in patients with clinical heart failure and sinus rhythm.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Criteria

Men and women with clinical heart failure, sinus rhythm, and an ejection fraction less than or equal to 45 percent.